Ocugen is trading at MXN 16.00, down 5.88%; macro and sector weakness are the likeliest context, with no confirmed company-specific catalyst.
- Hotter-than-expected core inflation lifted rate concerns and weighed on growth stocks.
- The October 14 OCU400 licensing announcement was positive, covering MENA rights and potential milestones and royalties—not adverse news.